$INJ is up 2.5% after a 24‑hour jump to $8.148, but that alone doesn’t signal a lasting trend. The latest headline about a Nasdaq ETF for Injective is interesting—if that ETF launches, it could bring institutional flow, but the ETF’s performance will depend on broader market sentiment and liquidity. For now, I see $INJ as a neutral play: it’s above the 7.778 support but still below the 8.584 resistance, so a short‑term rebound could happen, but a reversal is also possible if the market stays bearish. I’ll keep an eye on the ETF news and the overall crypto climate. DYOR.